Search Results

Castle Biosciences, Inc., a company improving health through innovative tests that guide patient care, announced new data from a study further confirming the performance of its DecisionDx-UM test as a robust independent predictor of metastasis-free survival in patients diagnosed with UM.

ExCellThera Inc. (ExCellThera), a world leader in blood stem cell expansion and fitness, announced today several UM171 presentations, including an oral session on new data from Phase 2 studies of investigational UM171 cell therapy in high-risk blood cancer patients, at the 65th American Society of Hematology Annual Meeting & Exposition (ASH), taking place December 9-12, 2023, in San Diego, California.

uMed, the health and research technology company, today announced The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has selected its service to support the global expansion of its wide-scale study exploring the link between loss of smell and brain disease.